Publications by authors named "Fusataka Koide"

Claim this Profile
I
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates.
Mayanka Awasthi, Anthony Macaluso, Dawn Myscofski, Jon Prigge, Fusataka Koide

Vaccines (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates.
Parikshit Tyagi, Milan Ganguly, Satyaprasad Manney, Kuntinath Wadkar, Nilesh Ingle, Fusataka Koide

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge.
Ryan S Noyce, Landon W Westfall, Siobhan Fogarty, Karen Gilbert, Onesmo Mpanju, Fusataka Koide

Viruses· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes.
Raj Kalkeri, Zhaohui Cai, Shuling Lin, John Farmer, Yury V Kuzmichev, Fusataka Koide

Microorganisms· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the gut microbiome community of nonhuman primates following radiation injury.
Raj Kalkeri, Kevin Walters, William Van Der Pol, Braden C McFarland, Nathan Fisher, Fusataka Koide

BMC Microbiol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Well-balanced immune response and protective efficacy induced by a single dose of live attenuated tetravalent dengue vaccine (KD-382) in monkeys.
Masaya Yoshimura, Yasuhiko Shinmura, Shota Takagi, Kazuhisa Kameyama, Kengo Sonoda, Fusataka Koide

Heliyon· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.
Natalie A Prow, Liang Liu, Mary K McCarthy, Kevin Walters, Raj Kalkeri, Fusataka Koide

NPJ Vaccines· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Pathogenesis of Asian and African-Lineage Zika Virus in Indian Rhesus Macaque's and Development of a Non-Human Primate Model Suitable for the Evaluation of New Drugs and Vaccines.
Jonathan O Rayner, Raj Kalkeri, Scott Goebel, Zhaohui Cai, Brian Green, Fusataka Koide

Viruses· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Beth Snyder, Scott Goebel, Fusataka Koide, Roger Ptak, Raj Kalkeri

J Med Virol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensitive virus yield assay for evaluation of Antivirals against Zika Virus.
Scott Goebel, Beth Snyder, Timothy Sellati, Mohammad Saeed, Roger Ptak, Fusataka Koide

J Virol Methods· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Zika Virus Infection Model in Cynomolgus Macaques.
Fusataka Koide, Scott Goebel, Beth Snyder, Kevin B Walters, Alison Gast

Front Microbiol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of minimal tumor burden on antibody response to vaccination.
Soo-Kie Kim, Xiaohong Wu, Govind Ragupathi, John Gathuru, Fusataka Koide

Cancer Immunol Immunother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.
Govind Ragupathi, Fusataka Koide, Philip O Livingston, Young Shin Cho, Atsushi Endo

J Am Chem Soc· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of DHBcAg as a potent carrier protein comparable to KLH for augmenting MUC1 antigenicity.
John K Gathuru, Fusataka Koide, Govind Ragupathi, Janet L Adams, Robnet T Kerns

Vaccine· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
Govind Ragupathi, Fusataka Koide, Natarajan Sathyan, Ella Kagan, Maria Spassova

Cancer Immunol Immunother· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.
Govindaswami Ragupathi, Don M Coltart, Lawrence J Williams, Fusataka Koide, Ella Kagan

Proc Natl Acad Sci U S A· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis